SIREN : 492487228
ART-MED is a French company founded 19 years ago, specialized in the sector Construction d'autres bâtiments. Based in YERRES (91330), this company of category PME shows in 2014 a revenue of 2.5 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2014 | 2013 |
|---|---|---|
| Revenue | 2 504 888 € | N/C |
| Net income | 16 480 € | 12 955 € |
| EBITDA | 44 088 € | -2 143 443 € |
| Net margin | 0.7% | N/C |
In 2014, ART-MED achieves revenue of 2.5 M€. After deducting consumption (634 k€), gross margin stands at 1.9 M€, i.e. a rate of 75%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 44 k€, representing 1.8% of revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 16 k€, i.e. 0.7% of revenue. This profit can be retained or distributed to shareholders.
2 504 888 €
1 870 454 €
44 088 €
15 356 €
16 480 €
1.8%
The debt ratio (= Financial debt / Equity x 100) stands at 148%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 5%. Low autonomy: the company heavily depends on external financing (banks, suppliers). Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 1.1 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 1.1% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
148.195%
5.18%
1.111%
1.102
49.8%
In 2014, the debt ratio of ART-MED (148.19) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
In 2014, the financial autonomy of ART-MED (5.2%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2014, the repayment capacity of ART-MED (1.10) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
The liquidity ratio (= Current assets / Current liabilities) stands at 97.28. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 13.8x. Operating income very largely covers interest expenses: high safety margin.
97.281
13.766
In 2014, the liquidity ratio of ART-MED (97.28) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
In 2014, the interest coverage of ART-MED (13.8x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 66 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 82 days. Favorable situation: supplier credit is longer than customer credit by 16 days. Inventory turnover is 47 days (= Average inventory / Cost of goods x 360). Overall, WCR represents 84 days of revenue, i.e. 584 k€ to permanently finance.
583 614 €
66 j
82 j
47 j
84 j
Based on 113 transactions of similar company sales (all years), the value of ART-MED is estimated at 171 291 € (range 90 625€ - 461 814€). With an EBITDA of 44 088€, the sector multiple of 3.6x is applied. The price/revenue ratio is 0.11x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 113 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare ART-MED with other companies in the same sector:
Voir toutes les statistiques du secteur Construction d'autres bâtiments
The revenue of ART-MED in 2014 is 2.5 M€.
Yes, ART-MED generated a net profit of 16 k€ in 2014.
The headquarters of ART-MED is located in YERRES (91330), in the department Essonne.
The tax return of ART-MED is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
ART-MED operates in the sector Construction d'autres bâtiments (NAF code 41.20B). See the 'Sector positioning' section above to compare the company with its competitors.